Rheumatology News International

Access this journal onSciVerse ScienceDirect

Shaping the Future: Biologics From Population to Patient
Highlights of a Symposium

A supplement to Rheumatology News International and sponsored by Schering-Plough.
The articles in this supplement are based on presentations made at a satellite symposium held on June 12, 2009 in Copenhagen, Denmark.

• Contents
• Faculty/Faculty Disclosures

To view the supplement, click the image above.

Contents

1. Introduction

2. Changing Lives of Patients With RA

3. Advancing Therapies in Psoriatic Arthritis (PsA) and Ankylosing Spondylitis (AS)

4. Rheumatoid Arthritis: Insights, Strategies & Expectations-The RAISE Patient Needs Survey

Faculty/Faculty Disclosures

Edward C. Keystone, MD, FRCP(C)- Chair
Professor of Medicine, University of Toronto
Director, The Rebecca MacDonald Centre for Arthritis and Autoimmune Disease
Toronto, Ontario, Canada
Professor Keystone has nothing to disclose.

Josef S. Smolen, MD
Division of Rheumatology
Department of Internal Medicine III
Medical University of Vienna
Vienna, Austria
Professor Smolen has received honoraria from Schering-Plough.

Paul Emery, MA, MD, FRCP
arc Professor of Rheumatology
Head of Section, Musculoskeletal Disease
Leeds Institute of Molecular Medicine, University of Leeds
Clinical Director (Rheumatology), Director - Leeds MSK
Biomedical Research Unit
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom
Professor Emery has a consulting agreement with Schering-Plough Corporation.

Iain B. McInnes, MD, PhD, FRCP
Professor of Experimental Medicine
Head of Division of Immunology, Infection and Inflammation
Glasgow Biomedical Research Centre
University of Glasgow
Glasgow, United Kingdom
Professor McInnes has received honoraria, or clinical grant funding from, or has served on advisory boards for, Schering-Plough.